The US Food and Drug Administration (FDA) has received a premarket tobacco product application (PMTA) from Canadian manufacturer TJP Labs for its L!X nicotine pouches. The company said its application to sell the pouches in the US is now moving on to the next step of the PMTA process.

TJP’s CEO David Richmond-Peck said the pouches were launched by its subsidiary L!X Innovations for adults who could not or chose not to quit nicotine but wished to drop cigarettes in favour of non-combustible, oral-use products.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

Shop reports

Request a free sample of this report:

“ TJP aims to put its Canadian-made L!X nicotine pouches onto the US market ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ TJP aims to put its Canadian-made L!X nicotine pouches onto the US market ”






      The US Food and Drug Administration (FDA) has received a premarket tobacco product application (PMTA) from Canadian manufacturer TJP Labs for its L!X nicotine pouches. The company said its application to sell the pouches in the US is now moving on to the next step of the PMTA process.

      TJP’s CEO David Richmond-Peck said the pouches were launched by its subsidiary L!X Innovations for adults who could not or chose not to quit nicotine but wished to drop cigarettes in favour of non-combustible, oral-use products.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik